Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling
Hyunju Lee, Hyang‐Sook Hoe
Pharmacological Research (2023) Vol. 190, pp. 106725-106725
Open Access | Times Cited: 24

Showing 24 citing articles:

Conformation states of DYRK1A affected by phosphorylation: Explorations from GaMD simulations and deep learning
Jian Wang, Feng Wang, Wanchun Yang, et al.
Journal of Molecular Liquids (2025) Vol. 424, pp. 127066-127066
Closed Access | Times Cited: 2
The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors
Sami G. Almalki
Pathology - Research and Practice (2023) Vol. 251, pp. 154854-154854
Closed Access | Times Cited: 28
CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network
Youjun She, Zihan Guo, Qing Zhai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Shrimp peptide QMDDQ improves scopolamine-induced memory impairments by activating the Notch1 signaling pathway
Peng-Fei Yan, Junchao Wang, Xiyu Zhao, et al.
Food Bioscience (2025), pp. 106041-106041
Closed Access
Harnessing network pharmacology and in silico drug discovery to uncover new targets and therapeutics for Alzheimer's disease
Haitham Al‐Madhagi, Husam Nassar
Computers in Biology and Medicine (2025) Vol. 187, pp. 109781-109781
Closed Access
Mouse-to-human modeling of microglia single-nuclei transcriptomics identifies immune signaling pathways and potential therapeutic candidates associated with Alzheimer's disease
Alexander Bergendorf, Jee Hyun Park, Brendan K. Ball, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Impact of Peripheral Inflammation on Blood–Brain Barrier Dysfunction and Its Role in Neurodegenerative Diseases
Ana Isabel Beltrán-Velasco, Vicente Javier Clemente‐Suárez
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2440-2440
Open Access
In Silico Pharmacological and Pharmacokinetic Study of Marmeline From Bael Fruit for the Treatment of Alzheimer’s Disease
Tassanee Ongtanasup, Onkamon Jampa, Nattawan Suwannakul, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2025) Vol. 2025, Iss. 1
Open Access
Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer’s disease: a focus on signaling mechanisms
Jianping Han, Xue Zhang, Lixing Kang, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Delivery of CDNF by AAV-mediated gene transfer protects dopamine neurons and regulates ER stress and inflammation in an acute MPTP mouse model of Parkinson’s disease
Jin Han Nam, Christopher T. Richie, Brandon K. Harvey, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
MicroRNA-based interventions in aberrant cell cycle diseases: Therapeutic strategies for cancers, central nervous system disorders and comorbidities
Xiaojuan Tang, Yuan Ren, Wen Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116979-116979
Open Access | Times Cited: 2
Secretase promotes AD progression: simultaneously cleave Notch and APP
Ke-Fan Yang, Jingyi Zhang, Mei Feng, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Developing theragnostics for Alzheimer's disease: Insights from cancer treatment
Hyunju Lee, Hee-Jeong Choi, Yoo Joo Jeong, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131925-131925
Open Access | Times Cited: 2
Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine
Pankaj Kadyan, Lovedeep Singh
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 665-678
Closed Access | Times Cited: 2
The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta
Sehyun Chae, Hyunju Lee, Ha-Eun Lee, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 2
Omaveloxolone ameliorates cognitive dysfunction in APP/PS1 mice by stabilizing the STAT3 pathway
Xiaolin Cui, Shuai Zong, Wenao Song, et al.
Life Sciences (2023) Vol. 335, pp. 122261-122261
Open Access | Times Cited: 5
Identification of immune infiltration and PANoptosis‐related molecular clusters and predictive model in Alzheimer's disease based on transcriptome analysis
Jin‐Lin Mei, Shi‐Feng Wang, Yang‐Yang Zhao, et al.
Ibrain (2024)
Open Access | Times Cited: 1
Up-regulation of myelin-associated glycoprotein is associated with the ameliorating effect of Omega-3 polyunsaturated fatty acids on Alzheimer's disease progression in APP-PS1 transgenic mice
Yan Shao, Fei Li, Bo Zou, et al.
Food & Function (2024) Vol. 15, Iss. 22, pp. 11236-11251
Closed Access | Times Cited: 1
Clearing Amyloid-Beta by Astrocytes: The Role of Rho GTPases Signaling Pathways as Potential Therapeutic Targets
Kyung Ah Park, Zhen Jin, Hui Lü, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1239-1239
Open Access | Times Cited: 1
Gadolinium-Based Magnetic Resonance Theranostic Agent with Gallic Acid as an Anti-Neuroinflammatory and Antioxidant Agent
Bokyung Sung, Dongwook Hwang, Ahrum Baek, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 204-204
Open Access
Role of Metalloproteinases in Diabetes-associated Mild Cognitive Impairment
Vitória Mattos Pereira, Suyasha Pradhanang, Jonathan F. Prather, et al.
Current Neuropharmacology (2024) Vol. 23, Iss. 1, pp. 58-74
Closed Access
The Influence of Antidiabetic Medications on Diagnostic Accuracy of Plasma Tau 217 Assay
Hisham N. Altayb, Fahad A. Al‐Abbasi, Firoz Anwar
Current Pharmaceutical Design (2024) Vol. 30, Iss. 40, pp. 3153-3154
Closed Access
Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD
Hyunju Lee, Jeong-Woo Hwang, Ji‐Eun Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Bioactivated Glucoraphanin Improves Cell Survival, Upregulating Phospho-AKT, and Modulates Genes Involved in DNA Repair in an In Vitro Alzheimer’s Disease Model: A Network-Transcriptomic Analysis
Aurelio Minuti, Emanuela Mazzon, Renato Iori, et al.
Nutrients (2024) Vol. 16, Iss. 23, pp. 4202-4202
Open Access
Page 1

Scroll to top